1921
Volume 85, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

The introduction of antibiotic therapy as first-line treatment of Buruli ulcer underlines the importance of laboratory confirmation of clinical diagnosis. Because smear microscopy has very limited sensitivity, the technically demanding and more expensive diagnostic polymerase chain reaction (PCR) has become the main method for confirmation. By optimization of the release of mycobacteria from swab specimen and concentration of bacterial suspensions before smearing, we were able to improve the detection rate of acid-fast bacilli by microscopy after Ziehl–Neelsen staining. Compared with PCR, which is the gold standard diagnostic method, the sensitivity and specificity of microscopy with 100 concentrated specimens were 58.4% and 95.7%, respectively. We subsequently evaluated a stepwise laboratory confirmation algorithm with detection of AFB as first-line method and PCR performed only with those samples that were negative in microscopic analysis. This stepwise approach reduced unit cost by more than 50% to $5.41, and the total costs were reduced from $917 to $433.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2011.11-0362
2011-11-01
2017-09-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/85/5/900.html?itemId=/content/journals/10.4269/ajtmh.2011.11-0362&mimeType=html&fmt=ahah

References

  1. Asiedu K, Sherpbier R, Raviglione MC, , 2000. Buruli Ulcer Mycobacterium ulcerans Infection . WHO Global Buruli Ulcer Initiative. Report 2000. Geneva, Switzerland: World Health Organization.
  2. Wansbrough-Jones M, Phillips R, , 2006. Buruli ulcer: emerging from obscurity. Lancet 367: 18491858.[Crossref]
  3. Portaels F, Johnson P, Meyers WM, , 2001. Diagnosis of Mycobacterium ulcerans Disease. Geneva, Switzerland: World Health Organization.
  4. Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson W, Klutse E, Crofts K, Massavon W, Etuaful S, Thompson R, Asamoah-Opare K, Racz P, Vloten F, Berberich VC, Kruppa T, Ampadu E, Fleischer B, Adjei O, , 2007. A stepwise approach to the laboratory diagnosis of Buruli ulcer disease. Trop Med Int Health 12: 8996.
  5. Eddyani M, Debacker M, Martin A, Aguiar J, Johnson CR, Uwizeye C, Fissette K, Portaels F, , 2008. Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semisolid transport medium. J Clin Microbiol 46: 6972.[Crossref]
  6. van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K, , 1999. Mycobacterium ulcerans infection. Lancet 354: 10131018.[Crossref]
  7. Semret M, Koromihis G, MacLean JD, Libman M, Ward BJ, , 1999. Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. Am J Trop Med Hyg 61: 689693.
  8. Evans MR, Phillips R, Etuaful SN, Amofah G, Adomako J, Adjei O, Dennis-Antwi J, Lucas SB, Wansbrough-Jones MH, , 2003. An outreach education and treatment project in Ghana for the early stage of Mycobacterium ulcerans disease. Trans R Soc Trop Med Hyg 97: 159160.[Crossref]
  9. Coloma JN, Navarrete-Franco G, Iribe P, Lopez-Cepeda LD, , 2005. Ulcerative cutaneous mycobacteriosis due to Mycobacterium ulcerans: report of two Mexican cases. Int J Lepr Other Mycobact Dis 73: 512.[Crossref]
  10. Revill WD, Morrow RH, Pike MC, Ateng J, , 1973. A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine. Lancet 2: 873877.[Crossref]
  11. Guarner J, Bartlett J, Whitney EA, Raghunathan PL, Stienstra Y, Asamoa K, Etuaful S, Klutse E, Quarshie E, van der Werf TS, van der Graaf WTA, King CH, Ashford DA, , 2003. Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis 9: 651656.[Crossref]
  12. Stienstra Y, van der Werf TS, Guarner J, Raghunathan RL, Whitney EAS, van der Graaf WTA, Asamoa K, Tappero JW, Ashford DA, King CH, , 2003. Analysis of an IS2404-based nested PCR for diagnosis of Buruli ulcer disease in regions of Ghana where the disease is endemic. J Clin Microbiol 41: 794797.[Crossref]
  13. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Guedenon A, Scott JT, Dramaix M, Portaels F, , 2004. Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997–2001. Emerg Infect Dis 10: 13911398.[Crossref]
  14. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, Phillips R, Evans M, Ofori-Adjei D, Klustse E, Owusu-Boateng J, Amedofu GK, Awuah P, Ampadu E, Amofah G, Asiedu K, Wansbrough-Jones M, , 2005. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 49: 31823186.[Crossref]
  15. Phillips RO, Sarfo FS, Osei-Sarpong F, Boateng A, Tetteh I, Lartey A, Adentwe W, Opare W, Asiedu KB, Wansbrough-Jones M, , 2009. Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer. J Clin Microbiol 47: 924926.[Crossref]
  16. Fyfe JAM, Lavender CJ, Johnson PDR, Globan M, Sievers A, Azuolas J, Stinear TP, , 2007. Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol 73: 47334740.[Crossref]
  17. Mensah-Quainoo E, Yeboah-Manu D, Asebi C, Patafuor F, Ofori-Adjei D, Junghanss T, Pluschke G, , 2008. Diagnosis of Mycobacterium ulcerans infection (Buruli ulcer) at a treatment centre in Ghana: a retrospective analysis of laboratory results of clinically diagnosed cases. Trop Med Int Health 13: 191198.[Crossref]
  18. Siegmund V, Adjei O, Nitschke J, Thompson W, Klutse E, Herbinger KH, Thompson R, van Vloten F, Racz P, Fleischer B, Loescher T, Bretzel G, , 2007. Dry reagent-based polymerase chain reaction compared with other laboratory methods available for the diagnosis of Buruli ulcer disease. Clin Infect Dis 45: 6875.[Crossref]
  19. Cattamanchi A, Dowdy DW, Davis JL, Worodria W, Yoo S, Joloba N, Matovu J, Hopewell PC, Huang L, , 2009. Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis. BMC Infect Dis 9: 53.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2011.11-0362
Loading
/content/journals/10.4269/ajtmh.2011.11-0362
Loading

Data & Media loading...

  • Received : 08 Jun 2011
  • Accepted : 27 Jun 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error